Novartis Home

Male scientist in lab working with his colleagues

At Novartis, we are reimagining medicine

Novartis COVID-19 Information Center

Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.

Enter

Annual Reporting 2020

Explore digital versions of the Annual Review 2020, Novartis in Society ESG Report 2020 and previous reports in the Annual Reporting microsite.

Learn More

From Cancer to Cures

Our new monthly series "Let's Talk About the C Word: From Cancer to Cures" featuring President of Novartis Oncology Dr. Susanne Schaffert, addresses challenging cancer related topics.

Learn More

Stepping toward a future with cell and gene therapy

Explore this video series about lives that have been touched by this new era of medicine.

Learn More

Novartis ranks second in 2021 Access to Medicine Index

Novartis maintained its position in the 2021 Access to Medicine Index, leading in its approach to product delivery, while performing strongly across all other areas of the Index.

Learn More

Our commitment to ethical and responsible use of AI

AI is helping Novartis improve patients’ lives and optimize the healthcare ecosystem. We are committed to deploying AI systems in a transparent and responsible way.

Learn More

Fortune World’s Most Admired Companies

Novartis rises in the pharmaceutical category of Fortune’s World’s Most Admired Companies list.

Learn More

Clinical Trials at Novartis

Discover how patients and healthy volunteers get involved in clinical trials to help bring innovative medicines to people.

Learn More

Our People and Culture

Inspired, Curious and Unbossed are the three pillars of the culture we build to bring out the best in our people.

Learn More

Our commitment to doing what's right

Novartis is committed to ensuring our associates are empowered to do what’s right. On September 01, 2020, we introduced a new Code of Ethics for Novartis.

Learn More